LINE

Text:AAAPrint
Learning Chinese

HPV疫苗

1
2016-07-19 13:54China Daily Editor: Yao Lan

HPV疫苗

HPV vaccine

The first vaccine for the human papilloma virus has been licensed for use on the Chinese mainland.

首个人乳头状瘤病毒疫苗获准在中国大陆使用.

Cervarix, produced by Glaxo Smith Kline, has been registered for use in girls and women aged between 9 and 25 with a three dose schedule within six months.

葛兰素史克生产的希瑞适在中国注册用于9到25岁的女性接种,采用6个月内3剂接种程序.

HPV(Human papillomavirus)中文名称为人类乳头瘤病毒,主要通过性传播(sexually transmitted),目前约有170种类型的HPV被判别出来,其中约有30到40种会通过性行为传染到生殖器及周边皮肤.

HPV感染可引起女性子宫颈癌(cervical cancer)、阴道癌(vaginal cancer)和外阴癌(vulvar cancer),男性阴茎癌(penile cancer),以及男女肛门癌(anal cancer)、喉癌(cancer of the back of the throat,oropharynx)和生殖器疣病.

HPV vaccine(HPV 疫苗)目前有两种:

默沙东公司研发的四价疫苗"佳达修"(Gardasil),可用于防治HPV16、18、6、11型病毒;

葛兰素史克(GSK)公司研发的二价疫苗"希瑞适"(Cervarix),该疫苗只针对HPV16和HPV18病毒的感染.

明年有望在国内上市的二价疫苗"希瑞适"(Cervarix)预防的HPV16和HPV18型病毒为引发宫颈癌的两种主要病毒.有研究显示,70%的宫颈癌发生都与HPV16、HPV18有关.

HPV疫苗的首选接种人群为青春期女性(teenage girls).国内推荐的年龄为9到25岁,最好在有性生活之前完成接种.美国CDC免疫实践委员会(ACIP)推荐11或12岁时进行疫苗接种,13-26岁已有性生活的女性也可以补种.世界卫生组织(WHO)推荐的接种人群为9-12岁.美国食品药品监督管理局(FDA)批准HPV疫苗的应用年龄为9-26岁.

因该类疫苗上市时间较短,目前还不能确定接种HPV疫苗后能否终生免疫(life-long protection). 

  

Related news

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

News
Politics
Business
Society
Culture
Military
Sci-tech
Entertainment
Sports
Odd
Features
Biz
Economy
Travel
Travel News
Travel Types
Events
Food
Hotel
Bar & Club
Architecture
Gallery
Photo
CNS Photo
Video
Video
Learning Chinese
Learn About China
Social Chinese
Business Chinese
Buzz Words
Bilingual
Resources
ECNS Wire
Special Coverage
Infographics
Voices
LINE
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2018 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.